Synaptic Polarity Depends on Phosphatidylinositol Signaling Regulated by myo-Inositol Monophosphatase in Caenorhabditis elegans

被引:17
|
作者
Kimata, Tsubasa
Tanizawa, Yoshinori
Can, Yoko
Ikeda, Shingo
Kuhara, Atsushi
Mori, Ikue [1 ,2 ]
机构
[1] Nagoya Univ, Dept Mol Biol, Mol Neurobiol Lab, Div Biol Sci,Grad Sch Sci, Nagoya, Aichi 4648602, Japan
[2] CREST, Tokyo 1020075, Japan
基金
日本学术振兴会; 日本科学技术振兴机构;
关键词
LITHIUM-TREATED RATS; C-ELEGANS; BIPOLAR DISORDER; NERVOUS-SYSTEM; UNIFYING HYPOTHESIS; INOSITOL DEPLETION; NEURONAL POLARITY; CANDIDATE GENE; KNOCKOUT MICE; BRAIN;
D O I
10.1534/genetics.111.137844
中图分类号
Q3 [遗传学];
学科分类号
071007 ; 090102 ;
摘要
Although neurons are highly polarized, how neuronal polarity is generated remains poorly understood. An evolutionarily conserved inositol-producing enzyme myo-inositol monophosphatase ( IMPase) is essential for polarized localization of synaptic molecules in Caenorhabditis elegans and can be inhibited by lithium, a drug for bipolar disorder. The synaptic defect of IMPase mutants causes defects in sensory behaviors including thermotaxis. Here we show that the abnormalities of IMPase mutants can be suppressed by mutations in two enzymes, phospholipase C beta or synaptojanin, which presumably reduce the level of membrane phosphatidylinositol 4,5-bisphosphate (PIP2). We also found that mutations in phospholipase C beta conferred resistance to lithium treatment. Our results suggest that reduction of PIP2 on plasma membrane is a major cause of abnormal synaptic polarity in IMPase mutants and provide the first in vivo evidence that lithium impairs neuronal PIP2 synthesis through inhibition of IMPase. We propose that the PIP2 signaling regulated by IMPase plays a novel and fundamental role in the synaptic polarity.
引用
收藏
页码:509 / U343
页数:21
相关论文
共 50 条
  • [31] Synthesis and structure revision of the myo-inositol monophosphatase inhibitor L-671,776
    Falck, JR
    Reddy, KK
    Chandrasekhar, S
    TETRAHEDRON LETTERS, 1997, 38 (30) : 5245 - 5248
  • [32] High-resolution structure of myo-inositol monophosphatase, the putative target of lithium therapy
    Gill, R
    Mohammed, F
    Badyal, R
    Coates, L
    Erskine, P
    Thompson, D
    Cooper, J
    Gore, M
    Wood, S
    ACTA CRYSTALLOGRAPHICA SECTION D-STRUCTURAL BIOLOGY, 2005, 61 : 545 - 555
  • [33] Genomic structure and novel variants of myo-inositol monophosphatase 2 (IMPA2)
    Yoshikawa, T
    Padigaru, M
    Karkera, JD
    Sharma, M
    Berrettini, WH
    Esterling, LE
    Detera-Wadleigh, SD
    MOLECULAR PSYCHIATRY, 2000, 5 (02) : 165 - 171
  • [35] Balancing myo-inositol use in metabolic and signaling pathways
    Alford, Shannon Recca
    Gillaspy, Glenda E.
    FASEB JOURNAL, 2007, 21 (05): : A256 - A256
  • [36] Inversion of configuration during the hydrolysis of D-1-Sp-myo-inositol [17O]thiophosphate catalyzed by myo-inositol monophosphatase
    Fauroux, CMJ
    Lee, M
    Cullis, PM
    Douglas, KT
    Freeman, S
    Gore, MG
    JOURNAL OF THE AMERICAN CHEMICAL SOCIETY, 1999, 121 (36) : 8385 - 8386
  • [37] Human myo-inositol monophosphatase 2 rescues the nematode thermotaxis mutant ttx-7 more efficiently than IMPA1: functional and evolutionary considerations of the two mammalian myo-inositol monophosphatase genes
    Ohnishi, Tetsuo
    Tanizawa, Yoshinori
    Watanabe, Akiko
    Nakamura, Takemichi
    Ohba, Hisako
    Hirata, Haruna
    Kaneda, Chizu
    Iwayama, Yoshimi
    Arimoto, Takafumi
    Watanabe, Kazutada
    Mori, Ikue
    Yoshikawa, Takeo
    JOURNAL OF NEUROCHEMISTRY, 2013, 124 (05) : 685 - 694
  • [38] myo-inositol monophosphatase in the brain has zinc ion-dependent tyrosine phosphatase activity
    Fujimoto, S
    Tsuda, J
    Kawakami, N
    Tanino, H
    Shimohama, S
    GENERAL PHARMACOLOGY, 1998, 31 (03): : 469 - 475
  • [40] Binding of the Activating Ion Co(II) to myo-Inositol Monophosphatase Monitored by Fluorescence and Phosphorescence Spectroscopy
    Oh-Shin Kwon
    Jorge E. Churchich
    Journal of Protein Chemistry, 1997, 16 : 1 - 9